# Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

> **NCT04567225** · PHASE4 · TERMINATED · sponsor: **The Cleveland Clinic** · enrollment: 39 (actual)

## Conditions studied

- Diabetic Ketoacidosis
- Type 1 Diabetes
- Type 2 Diabetes

## Interventions

- **DRUG:** Early Glargine
- **DRUG:** Late Glargine
- **OTHER:** IV insulin infusion
- **OTHER:** IV fluid and electrolytes replacement

## Key facts

- **NCT ID:** NCT04567225
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-01
- **Primary completion:** 2021-08-27
- **Final completion:** 2021-08-27
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** Stopped after internal review
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04567225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04567225, "Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04567225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*